Episode 132: Navigating Nuances of Life Sciences Post-Closing, With Amy Cassalia

Episode 132: Navigating Nuances of Life Sciences Post-Closing, With Amy Cassalia

McGuireWoods partner and host Geoff Cockrell [https://insights.mcguirewoods.net/email_handler.aspx?sid=blankform&redirect=https%3a%2f%2fwww.mcguirewoods.com%2fpeople%2fc%2fgeoffrey-c-cockrell%2f&checksum=156A792A] invites colleague Amy Cassalia [https://insights.mcguirewoods.net/email_handler.aspx?sid=blankform&redirect=https%3a%2f%2fwww.mcguirewoods.com%2fpeople%2fc%2famy-e-cassalia%2f&checksum=06360F2D] — whose practice is heavily weighted on life sciences transactions — to share insights about the post-closing period of these complex deals. The wide-ranging conversation covers the dynamics of “contingent consideration,” investor risk and buyers’ leverage. Amy explains why she sees high-level use of contingent payments in life sciences deals and why the term “commercially reasonable” often becomes critical when a deal spirals into litigation. Stay tuned as she unpacks leading trends. Top among them? The increasing use of earn-outs. CONNECT AND LEARN MORE ☑️ Amy Cassalia [https://www.mcguirewoods.com/people/c/amy-e-cassalia/] | LinkedIn [https://www.linkedin.com/in/amy-cassalia-31106711] ☑️ Geoff Cockrell [https://www.mcguirewoods.com/people/c/geoffrey-c-cockrell/] | LinkedIn [https://www.linkedin.com/in/geoffrey-cockrell-02076110/] ☑️ McGuireWoods [https://www.mcguirewoods.com/] | LinkedIn [https://www.linkedin.com/company/mcguirewoods/] | Facebook [https://www.facebook.com/mcguirewoods] | Instagram [https://www.instagram.com/mcguirewoods_llp/] | X [https://twitter.com/McGuireWoodsLLP] ☑️ Subscribe Apple Podcasts [https://podcasts.apple.com/ph/podcast/the-corner-series/id1597490984] | Spotify [https://open.spotify.com/show/62wDhXTw09oQ6dGDfbJFiI] | Amazon Music [https://music.amazon.com/podcasts/4a022fe7-eb43-446a-b130-a33e5e23ef0b/the-corner-series] This podcast was recorded and is being made available by McGuireWoods for informational purposes only. By accessing this podcast, you acknowledge that McGuireWoods makes no warranty, guarantee, or representation as to the accuracy or sufficiency of the information featured in the podcast. The views, information, or opinions expressed during this podcast series are solely those of the individuals involved and do not necessarily reflect those of McGuireWoods. This podcast should not be used as a substitute for competent legal advice from a licensed professional attorney in your state and should not be construed as an offer to make or consider any investment or course of action.

Episode 131: GP-Led Secondaries in Lower Middle Market, With Chris Lawrence

The secondary market has grown to roughly $220 billion as GPs and LPs scramble for liquidity in a private markets cycle stuck in a “worse distribution profile” for three and a half years. Chris Lawrence [https://insights.mcguirewoods.net/email_handler.aspx?sid=blankform&redirect=https%3a%2f%2flabyrinthcapitalpartners.com%2flcp-team%2f&checksum=2687943F], managing partner at Labyrinth Capital Partners, joins McGuireWoods partner and host Geoff Cockrell [https://insights.mcguirewoods.net/email_handler.aspx?sid=blankform&redirect=https%3a%2f%2fwww.mcguirewoods.com%2fpeople%2fc%2fgeoffrey-c-cockrell%2f&checksum=156A792A] to demystify GP-led secondaries. Chris breaks down continuation vehicles, strip sales and fund restructurings. He explains why secondary pricing ranges from par to as low as 72 cents on the dollar and makes the case that GP-leds are now a mature, institutionally accepted portfolio management tool. CONNECT AND LEARN MORE ☑️ Chris Lawrence [https://labyrinthcapitalpartners.com/lcp-team/] | LinkedIn [https://www.linkedin.com/in/chris-lawrence-092b907/] ☑️ Labyrinth Capital Partners [https://labyrinthcapitalpartners.com/] on LinkedIn [https://www.linkedin.com/company/labyrinth-capital-partners/] ☑️ Geoff Cockrell [https://www.mcguirewoods.com/people/c/geoffrey-c-cockrell/] | LinkedIn [https://www.linkedin.com/in/geoffrey-cockrell-02076110/] ☑️ McGuireWoods [https://www.mcguirewoods.com/] | LinkedIn [https://www.linkedin.com/company/mcguirewoods/] | Facebook [https://www.facebook.com/mcguirewoods] | Instagram [https://www.instagram.com/mcguirewoods_llp/] | X [https://twitter.com/McGuireWoodsLLP] ☑️ Subscribe Apple Podcasts [https://podcasts.apple.com/ph/podcast/the-corner-series/id1597490984] | Spotify [https://open.spotify.com/show/62wDhXTw09oQ6dGDfbJFiI] | Amazon Music [https://music.amazon.com/podcasts/4a022fe7-eb43-446a-b130-a33e5e23ef0b/the-corner-series] This podcast was recorded and is being made available by McGuireWoods for informational purposes only. By accessing this podcast, you acknowledge that McGuireWoods makes no warranty, guarantee, or representation as to the accuracy or sufficiency of the information featured in the podcast. The views, information, or opinions expressed during this podcast series are solely those of the individuals involved and do not necessarily reflect those of McGuireWoods. This podcast should not be used as a substitute for competent legal advice from a licensed professional attorney in your state and should not be construed as an offer to make or consider any investment or course of action.

Episode 130: Oncology and Retina: Follow the Drug Spend, With Jeanne Proia

Oncology commands roughly 40% of the national drug spend. Retina is close behind. “If you follow the drug spend, you’ll find that the distributors are really building an ecosystem around it,” says Jeanne Proia [https://insights.mcguirewoods.net/email_handler.aspx?sid=blankform&redirect=https%3a%2f%2fwww.ckcap.com%2fmeet-our-team%2fjeanne-proia&checksum=8D863301], managing director at Cross Keys Capital and president of its healthcare services group. In this conversation with McGuireWoods partner and host Geoff Cockrell [https://insights.mcguirewoods.net/email_handler.aspx?sid=blankform&redirect=https%3a%2f%2fwww.mcguirewoods.com%2fpeople%2fc%2fgeoffrey-c-cockrell%2f&checksum=156A792A], Jeanne unpacks the market. Unlike traditional PE deals, she says, these transactions leave physicians holding their own equity inside a long-term MSO relationship, trading the second bite at the apple for cash upfront and taking the risk off. As she explains: “They’re able to bring a lot more synergies just because they’re getting to be bigger and bigger, and they can use that money to support all the synergies, whether it’s clinical trials, recruiting or RCM.” CONNECT AND LEARN MORE ☑️ Jeanne Proia [https://www.ckcap.com/meet-our-team/jeanne-proia] | LinkedIn [https://www.linkedin.com/in/jeanne-proia-b232a57/] ☑️ Cross Keys Capital [https://www.ckcap.com/] | LinkedIn [https://www.linkedin.com/company/cross-keys-capital-llc] ☑️ Geoff Cockrell [https://www.mcguirewoods.com/people/c/geoffrey-c-cockrell/] | LinkedIn [https://www.linkedin.com/in/geoffrey-cockrell-02076110/] ☑️ McGuireWoods [https://www.mcguirewoods.com/] | LinkedIn [https://www.linkedin.com/company/mcguirewoods/] | Facebook [https://www.facebook.com/mcguirewoods] | Instagram [https://www.instagram.com/mcguirewoods_llp/] | X [https://twitter.com/McGuireWoodsLLP] ☑️ Subscribe Apple Podcasts [https://podcasts.apple.com/ph/podcast/the-corner-series/id1597490984] | Spotify [https://open.spotify.com/show/62wDhXTw09oQ6dGDfbJFiI] | Amazon Music [https://music.amazon.com/podcasts/4a022fe7-eb43-446a-b130-a33e5e23ef0b/the-corner-series] This podcast was recorded and is being made available by McGuireWoods for informational purposes only. By accessing this podcast, you acknowledge that McGuireWoods makes no warranty, guarantee, or representation as to the accuracy or sufficiency of the information featured in the podcast. The views, information, or opinions expressed during this podcast series are solely those of the individuals involved and do not necessarily reflect those of McGuireWoods. This podcast should not be used as a substitute for competent legal advice from a licensed professional attorney in your state and should not be construed as an offer to make or consider any investment or course of action.

Episode 129 Special Crossover Edition: McGuireWoods Healthcare PE Conference Preview

This special episode is a crossover between The Corner Series and Provident’s Healthcare DealCast released across both McGuireWoods’ and Provident Healthcare Partners’ channels. McGuireWoods partner Geoff Cockrell [https://insights.mcguirewoods.net/email_handler.aspx?sid=blankform&redirect=https%3a%2f%2fwww.mcguirewoods.com%2fpeople%2fc%2fgeoffrey-c-cockrell%2f&checksum=156A792A] is joined by Steve Grassa [https://insights.mcguirewoods.net/email_handler.aspx?sid=blankform&redirect=https%3a%2f%2fwww.providenthp.com%2fteam%2fsteven-grassa-healthcare-ma-investment-banker%2f&checksum=5800B424], director of Provident Healthcare Partners, for a wide-ranging discussion on the healthcare services landscape including the provider services market, opportunities for emerging buyers and what defines an “A-caliber” asset. This conversation also serves as a preview of McGuireWoods’ Healthcare Private Equity Conference later this month, where Geoff will lead a banker-focused panel discussion. CONNECT AND LEARN MORE ☑️ Steve Grassa [https://www.providenthp.com/team/steven-grassa-healthcare-ma-investment-banker/] ☑️ Provident Healthcare Partners [https://www.providenthp.com/] on LinkedIn [https://www.linkedin.com/company/provident-healthcare-partners-llc] | YouTube [https://www.youtube.com/channel/UCx95KnRzBMn4As_THflC55Q] ☑️ Geoff Cockrell [https://www.mcguirewoods.com/people/c/geoffrey-c-cockrell/] | LinkedIn [https://www.linkedin.com/in/geoffrey-cockrell-02076110/] ☑️ McGuireWoods [https://www.mcguirewoods.com/] | LinkedIn [https://www.linkedin.com/company/mcguirewoods/] | Facebook [https://www.facebook.com/mcguirewoods] | Instagram [https://www.instagram.com/mcguirewoods_llp/] | X [https://twitter.com/McGuireWoodsLLP] ☑️ Subscribe Apple Podcasts [https://podcasts.apple.com/ph/podcast/the-corner-series/id1597490984] | Spotify [https://open.spotify.com/show/62wDhXTw09oQ6dGDfbJFiI] | Amazon Music [https://music.amazon.com/podcasts/4a022fe7-eb43-446a-b130-a33e5e23ef0b/the-corner-series] This podcast was recorded and is being made available by McGuireWoods for informational purposes only. By accessing this podcast, you acknowledge that McGuireWoods makes no warranty, guarantee, or representation as to the accuracy or sufficiency of the information featured in the podcast. The views, information, or opinions expressed during this podcast series are solely those of the individuals involved and do not necessarily reflect those of McGuireWoods. This podcast should not be used as a substitute for competent legal advice from a licensed professional attorney in your state and should not be construed as an offer to make or consider any investment or course of action.

Episode 128: Building a Gastroenterology Program That’s ‘Second to None’, With Matt Devine

How did Allied Digestive Health build a gastroenterology program that’s “second to none” with roughly 200 gastroenterologists across New York and New Jersey? CEO Matt Devine [https://insights.mcguirewoods.net/email_handler.aspx?sid=blankform&redirect=https%3a%2f%2fallieddigestivehealth.com%2fabout%2fabout-ahmso%2fleadership-matt-devine%2f&checksum=9D8E5289] unpacks the strategies, such as investing in technology and having one EMR across the platform that’s world class. “If we’re just going out and getting larger, that’s nice and that’s admirable. But what we really need to do at the end of the day is improve outcomes. And that’s what our doctors take pride in every day,” he tells McGuireWoods partner and host Geoff Cockrell [https://insights.mcguirewoods.net/email_handler.aspx?sid=blankform&redirect=https%3a%2f%2fwww.mcguirewoods.com%2fpeople%2fc%2fgeoffrey-c-cockrell%2f&checksum=156A792A]. Tune in for Matt’s insights about what Geoff calls the “triple aims” in healthcare: improving outcomes, improving access and controlling system cost. CONNECT AND LEARN MORE ☑️ Matt Devine [https://allieddigestivehealth.com/about/about-ahmso/leadership-matt-devine/] | LinkedIn [https://www.linkedin.com/in/matthew-devine-34343bb] ☑️ Allied Digestive Health [https://allieddigestivehealth.com/] | LinkedIn [https://www.linkedin.com/company/allied-digestive-health/] | Facebook [https://www.facebook.com/allieddigestivehealth] | Instagram [https://www.instagram.com/allieddigestivehealth/] | X [https://x.com/ADHGastro] | YouTube [https://www.youtube.com/@AlliedDigestiveHealth] ☑️ Geoff Cockrell [https://www.mcguirewoods.com/people/c/geoffrey-c-cockrell/] | LinkedIn [https://www.linkedin.com/in/geoffrey-cockrell-02076110/] ☑️ McGuireWoods [https://www.mcguirewoods.com/] | LinkedIn [https://www.linkedin.com/company/mcguirewoods/] | Facebook [https://www.facebook.com/mcguirewoods] | Instagram [https://www.instagram.com/mcguirewoods_llp/] | X [https://twitter.com/McGuireWoodsLLP] ☑️ Subscribe Apple Podcasts [https://podcasts.apple.com/ph/podcast/the-corner-series/id1597490984] | Spotify [https://open.spotify.com/show/62wDhXTw09oQ6dGDfbJFiI] | Amazon Music [https://music.amazon.com/podcasts/4a022fe7-eb43-446a-b130-a33e5e23ef0b/the-corner-series] This podcast was recorded and is being made available by McGuireWoods for informational purposes only. By accessing this podcast, you acknowledge that McGuireWoods makes no warranty, guarantee, or representation as to the accuracy or sufficiency of the information featured in the podcast. The views, information, or opinions expressed during this podcast series are solely those of the individuals involved and do not necessarily reflect those of McGuireWoods. This podcast should not be used as a substitute for competent legal advice from a licensed professional attorney in your state and should not be construed as an offer to make or consider any investment or course of action.